Skip to main content
. Author manuscript; available in PMC: 2014 Sep 12.
Published in final edited form as: J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1105–1111. doi: 10.1136/jnnp.2009.202556

Table 3.

Secondary outcome measures (± standard deviation) at baseline, 1 day, and at 1 and 3 months after the tDCS and sham intervention

Secondary outcome
measures
Baseline 1 day post-
intervention
p value
(95% CI)
1 month
post-
intervention
p value
(95% CI)
3 months
post-
intervention
p value
(95% CI)
tDCS
sham
UPDRS on 42.5 ± 10.8
39.5 ± 12.8
36.9 ± 11.1
32 ± 11.7
0.30 (−9.9, 3.1) 42.5 ± 7.8
36.1 ± 11
0.16 (−10.7, 1.87) 43.4 ± 9.1
35.5 ± 13.8
0.31 (−8.2, 2.6)
off 58.4 ± 14.7
53.6 ± 14.5
54.1 ± 13.1
50.4 ± 16.2
0.98 (−7.8, 7.7) 56.1 ± 13.2
54.4 ± 12.1
0.80 (−8.5, 6.6) 60.1 ± 13.6
52.4 ± 17
0.52 (−10.4, 5.3)
UPDRS (III) on 22.2 ± 8.7
17.5 ± 8
20.4 ± 7.7
15.6 ± 7.9
0.49 (−3.2, 1.5) 22.7 ± 6.6
18.6 ± 8.1
0.38 (−5.3, 2.1) 23.1 ± 7.8
17.6 ± 8.5
0.40 (−5.1, 2.1)
off 34 ± 10
26.5 ± 8.4
31.5 ± 7.3
29 ± 11.7
0.083 (−1.0, 7.9) 31.4 ±9.9
29 ± 8.1
0.54 (−3.2, 6.1) 34 ± 10.3
27.1 ± 10.5
0.81 (−5.6, 4.4)
UPDRS Bradykinesia* on 7.2 ± 2.5
6.8 ± 3.1
6.7 ± 3.1
5.8 ± 2.8
0.41 (−1.5, 0.6) 7.7 ± 2.5
7.8 ± 3.3
0.91 (−1.8, 1.6) 7.8 ± 3.1
6.8 ± 3.5
0.53 (−2.5, 1.3)
off 12 ± 4.3
9.5 ± 3.9
10.7 ± 4.7
10.3 ± 3.9
0.039 (0.099, 3.6) 11.2 ± 4.7
11.4 ± 4.4
0.13 (−0.4, 3.4) 11.8 ± 4.6
10.4 ± 4.5
0.40 (−1.2, 2.9)
SRTT reaction time (ms) 789 ± 247
755 ± 122
731 ± 315
773 ± 254
0.72 (−131.5, 188.7) 657 ± 153
777 ± 284
0.92 (−156.7, 148.9) 703 ± 299
753 ± 142
0.13 (−35.4, 272.5)
error rate (%) 17.6 ± 19.6
9.3 ± 12.8
17.7 ± 23.3
14.1 ± 18.3
0.27 (−0.04, 0.11) 14.1 ± 17.7
18.5 ± 23.3
0.18 (−0.02, 0.12) 26.1 ± 28.3
11.2 ± 12.5
0.52 (−0.07, 0.13)
BDI 10.4 ± 11.3
7 ± 4.2
7.5 ± 6.8
5.5 ± 3.8
0.48 (−2.2, 1.0) 6.5 ± 4.1
7.7 ± 6.5
0.19 (−1.5, 7.3) 8.0 ± 6.4
5.3 ± 5.1
0.49 (−4.7, 2.3)
Health survey (SF-12v2) physical health mental health 44.3 ± 7.2
38.1 ± 8.7
50.6 ± 9.7
48.7 ± 10.5
42.0 ± 7.9
41.0 ± 7.9
54.1 ± 7.0
52.5 ± 9.7
0.15 (−1.3, 7.9)
0.84 (−6.1, 5.0)
39 ± 8.9
41.1 ± 10.2
53.9 ± 10.0
52.7 ± 9.4
0.10 (−1.0, 11.1)
0.93 (−5.0, 5.5)
39.5 ± 8.7
38.5 ± 10.2
53.6 ± 8.3
50.2 ± 12.4
0.28 (−2.7, 9.1)
0.49 (−9.1, 4.5)
Self-assessment sleep (hrs) 6.6 ± 0.1
6.6 ± 0.1
6.9 ± 0.1
6.8 ± 0.1
0.48 (−0.14, 0.07) 6.4 ± 0.1
6.4 ± 0.1
0.93 (−0.08, 0.07) 6.7 ± 0.2
6.6 ± 0.1
0.25 (−0.22, 0.06)
on (hrs) 11.0 ± 0.3
11 ± 0.2
11.3 ± 0.3
11.4 ± 0.2
0.08 (−0.02, 0.28) 10.9 ± 0.1
10.9 ± 0.1
0.84 (−0.09, 0.11) 12.0 ± 0.1
12.1 ± 0.1
0.12 (−0.02, 0.16)
dyskinesias (hrs) 2.4 ± 0.1
2.5 ± 0.1
3.2 ± 0.2
3.2 ± 0.1
0.90 (−0.11, 0.10) 2.8 ± 0.1
2.9 ± 0.1
0.40 (−0.04, 0.10) 2.1 ±0.1
2.1 ± 0.1
0.89 (−0.8, 0.10)
off (hrs) 3.2 ± 0.3
3.2 ± 0.2
2.5 ± 0.3
2.4 ± 0.3
0.32 (−0.29, 0.09) 3.4 ± 0.1
3.4 ± 0.1
0.28 (−0.15, 0.04) 2.7 ± 0.2
2.7 ± 0.1
0.85 (−0.09, 0.08)
off tremor (hrs) 0.8 ± 0.2
0.8 ± 0.1
0.2 ± 0.1
0.1 ± 0.0
0.83 (−0.01, 0.02) 0.4 ± 0.1
0.4 ± 0.1
0.72 (−0.06, 0.08) 0.8 ± 0.1
0.8 ± 0.0
0.83 (−0.07, 0.08)

Results of tDCS and sham groups are presented in first and second row, respectively. 95% confidence intervals were obtained from the linear mixed effects models. BDI = Beck Depression Inventory

*

UPDRS Bradykinesia: composite UPDRS bradykinesia score consisting of items 23–25: finger tapping, opening/closing and pro-/supination of the hands.